Literature DB >> 8570883

Prevalence of asthma and asthma-like symptoms in three French cities.

F Neukirch1, I Pin, J Knani, C Henry, C Pison, R Liard, S Romazzini, J Bousquet.   

Abstract

BACKGROUND: This study is part of the European Community Respiratory Health Survey (ECRHS), which uses a common methodology in different areas throughout the world. This paper describes the prevalences of reported asthma, asthma-like symptoms and nasal allergies, their relationships to age group and sex, and the relationships of asthma-like symptoms to current asthma, in the general population aged 20-44 years of three French urban areas.
METHODS: The study population of 2804 subjects in Grenoble, 3774 in Montpellier and 3152 in Paris (18th district), randomly selected from electoral rolls, answered a postal questionnaire (stage I of ECRHS). The response rates were 77.8%, 68.6% and 74.4%, respectively.
RESULTS: The prevalences were approximately 14% for wheezing, 16% for chest tightness and 4.5% for nocturnal shortness of breath in the three areas. Asthma attacks in the last 12 months were reported by 2.7% of subjects in Grenoble, 3.5% of subjects in Montpellier and 4.0% of subjects in Paris (P = 0.02). For nasal allergies, the prevalences were 28.0%, 34.3% and 30.8%, respectively (P < 0.001). Asthma was inversely correlated to age (higher prevalence in the youngest) but was not related to sex. Neither age distribution nor sex ratio explained the differences between areas. Among the asthma-like symptoms, wheezing and nocturnal shortness of breath correlated strongly with asthma, chest tightness correlated moderately and nocturnal coughing correlated poorly.
CONCLUSION: The prevalences observed were higher than expected from previous comparable French studies in young adults. These results are consistent with the hypothesis of a recent increase of asthma and allergies.

Entities:  

Mesh:

Year:  1995        PMID: 8570883     DOI: 10.1016/0954-6111(95)90136-1

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  8 in total

1.  Mortality of elderly subjects with self-reported asthma in a French cohort, 1991-1996.

Authors:  C Dantzer; J F Tessier; C Nejjari; P Barberger-Gateau; J F Dartigues
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

2.  Respiratory status in dairy farmers in France; cross sectional and longitudinal analyses.

Authors:  H Chaudemanche; E Monnet; V Westeel; D Pernet; A Dubiez; C Perrin; J-J Laplante; A Depierre; J-C Dalphin
Journal:  Occup Environ Med       Date:  2003-11       Impact factor: 4.402

3.  Increase in prevalence and severity of asthma in young adults in Copenhagen.

Authors:  E F Hansen; Y Rappeport; J Vestbo; P Lange
Journal:  Thorax       Date:  2000-10       Impact factor: 9.139

4.  The distribution in specific IgE and the prevalence of allergic symptoms in 25-64-years old inhabitants of an eastern and a western German city--results from Augsburg and Erfurt.

Authors:  B Filipiak; J Heinrich; D Nowak; H E Wichmann
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

Review 5.  Gastroesophageal reflux disease in asthma: effects of medical and surgical antireflux therapy on asthma control.

Authors:  D J Bowrey; J H Peters; T R DeMeester
Journal:  Ann Surg       Date:  2000-02       Impact factor: 12.969

Review 6.  Allergic rhinitis in children : diagnosis and management strategies.

Authors:  William E Berger
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

7.  Respiratory Diseases in University Students Associated with Exposure to Residential Dampness or Mold.

Authors:  Mathieu Lanthier-Veilleux; Geneviève Baron; Mélissa Généreux
Journal:  Int J Environ Res Public Health       Date:  2016-11-18       Impact factor: 3.390

8.  BSACI guidelines for the management of allergic and non-allergic rhinitis.

Authors:  G K Scadding; S R Durham; R Mirakian; N S Jones; S C Leech; S Farooque; D Ryan; S M Walker; A T Clark; T A Dixon; S R A Jolles; N Siddique; P Cullinan; P H Howarth; S M Nasser
Journal:  Clin Exp Allergy       Date:  2008-01       Impact factor: 5.018

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.